NEWS and RESOURCES​​​​​​​​​​​​

​

​​​​​​

• Bayer’s Continued Restructuring Claims 2,000 Jobs and Thins Management Layers - by Tristan Manalac (5/13/25)

​

• GSK axes $625M TIGIT drug as midphase data disappoint, promoting partner iTeos to cut costs - by Nick Paul Taylor (5/13/25)

​

• Roche spotlights Perjeta's staying power with 10-year breast cancer survival results - by Zoey Becker (5/13/25)

​

• Dutch biotech Azafaros gains €132M series B to fund phase 3 trials of brain-penetrant drug - by James Waldron (5/13/25)

​

• Roche’s Genentech Earmarks $700M for North Carolina Plant as Billion-Dollar US Pledge Hangs in Balance - by Tristan Manalac (5/13/25)

​

​

Please contact us at info@gloveportsolutions.com with any comments